sinc
decemb
china
experienc
outbreak
novel
coronaviru
diseas
becom
newest
global
health
threat
peopl
infect
europ
unit
state
becom
epicent
total
confirm
case
april
respect
sever
case
develop
advers
outcom
number
death
persist
increas
outsid
china
case
fatal
ratio
itali
pandem
evolv
urgent
risk
factor
associ
fatal
outcom
identifi
earlier
intens
surveil
treatment
could
perform
save
live
previou
report
describ
clinic
characterist
patient
differ
subject
mild
sever
diseas
compar
nonetheless
previou
studi
limit
includ
rel
small
sampl
size
singlecent
observ
use
univari
analysi
alon
independ
predict
factor
fatal
outcom
remain
uncertain
also
suggest
use
singl
risk
factor
could
thoroughli
estim
comprehens
clinic
outcom
individu
patient
therefor
base
nation
cohort
current
studi
attempt
investig
potenti
risk
factor
associ
fatal
use
multivari
cox
regress
analysi
nomogram
model
led
nation
health
commiss
peopl
republ
china
retrospect
cohort
studi
admit
case
hospit
throughout
china
establish
diagnosi
made
base
world
health
organ
interim
guidanc
diagnosi
confirm
posit
result
realtim
revers
transcriptasepolymeras
chain
reaction
assay
highthroughput
sequenc
find
nasal
pharyng
swab
specimen
cutoff
time
januari
total
case
diagnos
laboratoryconfirm
collect
case
exclud
incomplet
medic
record
studi
approv
ethic
commiss
first
affili
hospit
guangzhou
medic
univers
institut
review
board
due
urgent
need
collect
data
emerg
infecti
diseas
requir
written
inform
consent
waiv
care
medic
chart
review
clinic
data
includ
epidemiolog
histori
demograph
data
clinic
symptom
sign
comorbid
radiolog
assess
laboratori
find
upon
admiss
treatment
clinic
outcom
extract
electron
medic
record
laboratori
assess
consist
cbc
blood
chemistri
coagul
test
liver
renal
function
electrolyt
creactiv
protein
procalcitonin
pct
lactat
dehydrogenas
creatin
kinas
medic
record
copi
sent
dataprocess
center
guangzhou
coordin
nation
health
commiss
team
experienc
respiratori
clinician
review
abstract
data
data
enter
computer
databas
crosscheck
core
data
miss
request
clarif
immedi
sent
coordin
subsequ
contact
primari
end
point
outcom
death
independ
predict
factor
associ
fatal
outcom
investig
continu
variabl
describ
use
mean
ae
sd
median
interquartil
rang
categor
variabl
describ
number
percentag
statist
comparison
continu
variabl
perform
independ
student
test
normal
distribut
data
otherwis
mannwhitney
u
test
perform
c
test
fisher
exact
test
appli
categor
variabl
appropri
surviv
curv
plot
use
kaplanmei
method
compar
use
logrank
test
cox
regress
analysi
use
univari
multivari
analys
estim
risk
factor
associ
fatal
outcom
variabl
includ
baselin
characterist
laboratori
find
assess
use
univari
cox
regress
analys
final
model
select
perform
via
backward
stepdown
select
process
akaik
inform
criterion
nomogram
built
base
result
multivari
analysi
rm
packag
r
version
r
foundat
statist
comput
http
wwwrprojectorg
maximum
score
variabl
set
perform
nomogram
measur
base
harrel
concord
index
cindex
nomogram
also
evalu
compar
nomogrampredict
observ
kaplanmei
estim
surviv
probabl
bootstrap
resampl
set
calibr
curv
calcul
use
regress
analysi
statist
analysi
perform
use
r
version
p
valu
consid
statist
signific
case
includ
cohort
death
report
januari
median
age
fatal
case
year
rang
year
subject
male
median
durat
initi
treatment
death
day
interquartil
rang
day
thirtyf
case
report
one
coexist
ill
hypertens
diabet
eight
coronari
heart
diseas
chd
six
cerebrovascular
diseas
cvd
six
copd
five
renal
diseas
fig
common
symptom
sinc
diseas
onset
fever
cough
dyspnea
incid
dyspnea
fatal
case
higher
nonfat
case
p
symptom
includ
fatigu
headach
myalgia
nausea
vomit
diarrhea
chill
e
tabl
admiss
follow
abnorm
laboratori
find
observ
fatal
case
lymphopenia
elev
level
creactiv
protein
lactos
dehydrogenas
ddimer
aspart
aminotransferas
ast
alanin
aminotransferas
leukocyt
pct
total
bilirubin
compar
nonfat
case
promin
laboratori
abnorm
abnorm
chest
radiograph
observ
fatal
case
ie
leukopenia
lymphopenia
elev
creactiv
protein
pct
lactos
dehydrogenas
ast
alanin
aminotransferas
total
bilirubin
creatin
kinas
creatinin
ddimer
level
accord
univari
analysi
e
tabl
patient
fatal
outcom
receiv
antibiot
therapi
antifung
therapi
administ
patient
receiv
oseltamivir
receiv
system
glucocorticoid
noninvas
ventil
niv
invas
mechan
ventil
imv
perform
case
respect
median
age
fatal
case
receiv
niv
imv
year
rang
year
year
rang
year
overal
case
given
extracorpor
membran
oxygen
continu
renal
replac
therapi
ard
secondari
infect
septic
shock
commonli
report
complic
fig
e
figur
show
progress
patient
fatal
outcom
multivari
cox
regress
model
display
independ
predict
factor
fatal
outcom
age
year
hazard
ratio
hr
ci
age
year
hr
ci
chd
hr
cvd
hr
ci
dyspnea
hr
pct
ngml
hr
ci
ast
ul
hr
ci
independ
risk
factor
associ
fatal
outcom
fig
kaplanmei
surviv
plot
prognost
factor
shown
figur
nomogram
construct
base
final
multivari
model
calcul
overal
surviv
probabl
first
identifi
factor
base
point
scale
top
nomogram
sum
point
factor
final
overal
surviv
probabl
obtain
base
bottom
point
scale
nomogram
fig
calibr
plot
bootstrap
resampl
valid
shown
figur
cindex
predict
overal
surviv
ci
indic
nomogram
consist
actual
observ
patient
studi
unravel
clinic
featur
risk
factor
fatal
outcom
subject
laboratoryconfirm
base
nation
cohort
januari
chestjournalorg
nation
health
commiss
document
patient
laboratoryconfirm
china
current
cohort
repres
infect
patient
abl
provid
panoram
pictur
regard
fatal
case
studi
independ
risk
factor
fatal
outcom
found
use
multivari
cox
regress
analysi
studi
first
develop
nomogram
model
accur
predict
clinic
outcom
patient
base
individu
characterist
risk
factor
prognost
nomogram
perform
well
predict
surviv
support
cindex
ci
calibr
curv
help
understand
improv
clinic
strategi
diseas
overal
confirm
case
fatal
ratio
current
cohort
resembl
march
world
health
organ
report
ie
lower
earlier
report
singl
site
wuhan
china
differ
may
due
difficulti
regard
insuffici
laboratori
diagnosi
abil
admiss
infect
patient
mild
symptom
earli
stage
diseas
outbreak
although
case
fatal
ratio
obvious
lower
sever
acut
respiratori
syndrom
sar
middl
eastern
respiratori
syndrom
transmiss
covid
seem
much
higher
recent
studi
found
sar
coronaviru
spike
approxim
higher
affin
sarscov
bind
function
hostcel
receptor
angiotensinconvert
enzym
may
potenti
mechan
larg
number
infect
peopl
around
world
consist
previou
report
current
studi
indic
age
group
suscept
howev
elderli
patient
sever
diseas
gener
higher
probabl
fatal
outcom
previou
report
indic
elderli
peopl
commonli
critic
ill
studi
show
advanc
age
strongest
risk
factor
fatal
outcom
also
found
risk
death
increas
patient
age
year
increas
patient
age
year
compar
patient
age
year
nomogram
model
age
import
predictor
show
equival
sex
distribut
infect
case
current
studi
indic
sex
core
factor
account
death
base
multivari
cox
regress
analysi
nonsurvivor
present
higher
proport
variou
coexist
chronic
ill
univari
analysi
previou
studi
report
similar
find
chd
cvd
confirm
independ
risk
factor
death
multivari
cox
regress
analysi
enter
nomogram
model
function
receptor
mainli
express
lung
alveolar
type
ii
epitheli
cell
also
blood
vessel
also
serv
neg
regulatori
factor
reninangiotensin
system
ra
via
axi
exhaust
could
activ
ra
enhanc
suscept
heart
failur
pulmonari
edema
may
act
similarli
sarscov
result
overactiv
ra
patient
preexist
chronic
cardiovascular
diseas
lead
fatal
outcom
although
hypertens
common
nonsurvivor
whether
ra
inhibitor
ace
inhibitor
angiotensin
ii
receptor
blocker
patient
hypertens
protector
requir
investig
dyspnea
diseas
onset
report
fatal
case
prove
independ
risk
factor
death
progress
diseas
case
hypoxemia
would
worsen
ard
may
develop
imper
identifi
patient
hypoxemia
provid
appropri
intervent
ard
common
complic
associ
death
follow
secondari
infect
septic
shock
patholog
evid
ard
case
show
obviou
desquam
pneumocyt
hyalin
membran
format
pulmonari
edema
similar
seen
sar
middl
east
respiratori
syndrom
coronaviru
infect
cohort
niv
imv
perform
fatal
case
respect
eleven
percent
case
manag
extracorpor
membran
oxygen
still
controversi
regard
use
highflow
nasal
cannula
hfnc
niv
patient
ard
howev
two
studi
indic
earli
applic
hfnc
hfnc
prone
posit
could
consid
firstlin
therapi
acut
respiratori
failur
may
help
avoid
intub
patient
ard
seri
laboratori
abnorm
admiss
common
fatal
case
compar
survivor
independ
laboratori
predictor
fatal
outcom
found
via
multivari
cox
regress
analysi
pct
calcitonin
propeptid
synthes
c
cell
thyroid
gland
releas
leukocyt
significantli
increas
bacteri
infect
sepsi
prove
high
specif
bacteri
infect
good
correl
sever
ill
pctguid
antibiot
stewardship
shown
reduc
antibiot
use
fewer
side
effect
improv
clinic
outcom
nomogram
model
current
studi
elev
level
pct
ngml
strong
reliabl
predictor
case
fatal
result
indic
secondari
bacteri
infect
earlier
stage
may
play
import
role
progress
diseas
elev
ast
ul
level
also
associ
greater
risk
death
nomogram
model
increas
creatinin
mmoll
total
bilirubin
mmoll
level
might
associ
fatal
outcom
wide
express
multipl
organ
besid
lung
possibl
could
invad
local
tissu
lead
direct
indirect
damag
ensu
activ
immun
respons
cytokin
storm
also
play
import
role
organ
dysfunct
overactiv
peripher
cell
present
increas
high
cytotox
cell
may
contribut
immun
injuri
sever
case
addit
use
nonsteroid
antiinflammatori
drug
antiviru
agent
antibiot
tradit
chines
medicin
may
associ
liver
renal
injuri
find
call
multidisciplinari
cooper
monitor
organ
dysfunct
current
studi
limit
first
case
incomplet
document
histori
symptom
laboratori
find
electron
databas
even
make
effort
regard
feedback
recollect
diagnos
coexist
ill
patient
selfreport
admiss
might
lead
recal
bia
although
cohort
broad
coverag
patient
region
nonrespons
bia
fulli
exclud
second
retrospect
observ
studi
current
could
set
valid
cohort
assess
predict
accuraci
due
urgent
timelin
special
situat
howev
use
bootstrap
resampl
cohort
show
cindex
ideal
suggest
nomogram
good
model
predict
outcom
likewis
calibr
curv
surviv
chestjournalorg
probabl
also
show
good
consist
predict
observ
collect
current
studi
provid
evid
advanc
age
dyspnea
chd
cvd
elev
pct
ast
level
independ
risk
factor
associ
fatal
outcom
nomogram
propos
studi
object
predict
prognosi
patient
earlier
identif
intens
surveil
appropri
therapi
consid
patient
high
risk
